EGFR and colitis: Our data support a model wherein TFF3 produced by goblet cells can bind the LINGO2 extracellular domain (NH2 terminal 350 AA) to de-repress inhibitory LINGO2-EGFR complexes, thereby allowing TFF3 to help maintain mucosal barrier integrity, suppress colitis, and promote immunity against GI helminths.